Status:
UNKNOWN
Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Emphysema
Eligibility:
All Genders
45-84 years
Brief Summary
The purpose of MESA-Lung is to assess the role of endothelial dysfunction and genetic susceptibility in subclinical COPD.
Detailed Description
Chronic obstructive pulmonary disease (COPD) is currently the fourth leading cause of death in the United States, and morbidity and mortality from COPD continue to rise. Despite the magnitude of the p...
Eligibility Criteria
Inclusion
- A random sample of MESA participants active at Exam 3 and/or 4.
Exclusion
- MESA participants without MESA Exam 3 or 4 measurements.
- MESA participants without FMD measurements in Exam 1.
- MESA participants who have not consented to genetic testing.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
4359 Patients enrolled
Trial Details
Trial ID
NCT00843271
Start Date
October 1 2004
End Date
November 1 2012
Last Update
January 16 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.